MHRA (Medicines and Healthcare products Regulatory Agency) study day on safe device use:
This article was originally published in Clinica
In a bid to promote the "crucial role of practice nurses in ensuring safe medical device use", the UK's Medicines and Healthcare products Regulatory Agency (MHRA) is hosting a Study Day for Practice Nurses, on September 27, in London. Topics include: the Device Evaluation Programme; point-of-care testing in primary care; adverse incident reporting; decontamination; devices in the home setting; and vaccination/immunisation. The event will be a one-off, the MHRA told Clinica. For information and registration, go to: www.mhra.gov.uk/conferences/register
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.